Siegfried-Col
Sector: Manufacturing (Industrial) • Location: Colombia
Source: International Finance Corporation (IFC)
Financing to Laboratorios Siegfried S.A.S (“Siegfried-Col”) and Laboratorios Siegfried, S.A. (jointly the “Borrowers”) to support the execution of their strategic plan including: (i) Capex needed to upgrade the manufacturing plant owned by Siegfried-Col, (ii) working capital requirements for the commercialization of Novartis’ products in light of the recent license-in agreement signed between the
- Status
- Prospective
- Sector
- Manufacturing (Industrial), Chemical (Industrial), Education, Government, Commercial
- Location
- Colombia
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about Siegfried-Col
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | active |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Financing to Laboratorios Siegfried S.A.S (“Siegfried-Col”) and Laboratorios Siegfried, S.A. (jointly the “Borrowers”) to support the execution of their strategic plan including: (i) Capex needed to upgrade the manufacturing plant owned by Siegfried-Col, (ii) working capital requirements for the commercialization of Novartis’ products in light of the recent license-in agreement signed between the Borrowers’ and Novartis; and (iii) reprofile the Borrowers’ existing debt with commercial banks to properly match the long-term nature of the investments undertaken by the Borrowers over the past years and free-up the cash needed to execute their strategic plan within the next 2-3 years (the “Project”). Siegfried-Col is a leading pharmaceutical company focused on the development, manufacture and commercialization of over-the-counter medicines, prescription drugs and personal care products (mostly branded generics). With two manufacturing plants in Colombia and 516 employees, Siegfried-Col is focused mainly on cardio, neuro, women’s health and primary care therapeutic areas. Approximately 95% of Siegfried-Col’s revenues are generated in Colombia, and the rest is exported to Central America, Ecuador, and Peru. |
Original sector | other |
Budget |
Location
Country | Colombia |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial), Chemical (Industrial), Education, Government, Commercial |
Article published date | 2025-08-08 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
